Andrea Varga

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Metastatic Breast Cancer

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard, Andres Cervantes, Valentina Gambardella, Erika Paige Hamilton, Antoine Italiano, Kevin M Kalinsky, Ian E Krop, Mafalda Oliveira, Peter Schmid, Cristina Saura, Nicholas C Turner, Andrea Varga, Sravanthi Cheeti, Stephanie Hilz, Katherine E Hutchinson, Yanling Jin, Stephanie Royer-Joo, Ubong Peters, Noopur Shankar, Jennifer L Schutzman, Dejan Juric
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, Ludovic Lacroix, Etienne Rouleau, Anas Gazzah, Rastilav Bahleda, David Planchard, Andrea Varga, Capucine Baldini, Sophie Postel-Vinay, Luc Friboulet, Yohann Loriot, Loic Verlingue, Arthur Geraud, Maud Ngo Camus, Claudio Nicotra, Jean Charles Soria, Fabrice André, Benjamin Besse, Christophe Massard, Antoine Italiano
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology. JCO precision oncology 6 (2022)
Andreas Schneeweiss, Dagmar Hess, Markus Joerger, Andrea Varga, Stacy Moulder, Apostolia M Tsimberidou, Cynthia Ma, Sara A Hurvitz, Christine Rentzsch, Marion Rudolph, Silke Thiele, Oliver Boix, Gary Wilkinson, Eleni Lagkadinou, Matthias Ocker
Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy. Cancers 11 (12) (2019)